Glioma angiogenesis is boosted by ELK3 activating the HIF-1[Formula: see text] /VEGF-A signaling axis

BACKGROUND: Clinical studies have shown that first-line use of anti-angiogenetic therapy can prolong progression-free survival but little progress has been made in extending the overall survival of the patients. We explored the role of ELK3 in glioma angiogenesis to improve and design more efficacio...

Descripción completa

Detalles Bibliográficos
Autores principales: Yueyang, Mou, Yaqin, Hu, Guolian, Xue, Wenjian, Zhao, Yang, Jiao, Chen, Li, Haiyan, Cao, Min, Chao, Jianping, Deng, Penggao, Dai, Hongli, Zhu, Liang, Wang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10347878/
https://www.ncbi.nlm.nih.gov/pubmed/37452291
http://dx.doi.org/10.1186/s12885-023-11069-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10347878/
https://www.ncbi.nlm.nih.gov/pubmed/37452291
http://dx.doi.org/10.1186/s12885-023-11069-w

Ejemplares similares